NCT04680871撤回不适用
Validation of In-Ear Sensor
适应症
试验速览
- 阶段
- 不适用
- 状态
- 撤回
- 试验地点
- 1
- 主要终点
- Biometric
研究概览
简要总结
The purpose of this study is to clinically validate noninvasive in-ear sensor.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 50 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Subject must have the ability to understand and provide written informed consent
- •Subject is an adult over 18 years of age (18 to 50 for Induced Febrile Subjects)
- •Subject must be willing and able to comply with study procedures and duration. Subject must be willing and able to comply with study procedures and duration. Must be available for at least 2 visits for ear molds and study conduct.
- •Male or female of any race
排除标准
- •Subject is considered as being morbidly obese (defined as BMI >39.5)
- •Compromised circulation, injury, or physical malformation of fingers, toes, hands, ears or forehead/skull or other sensor sites which would limit the ability to test sites needed for the study. (Note: Certain malformations may still allow subjects to participate if the condition is noted and would not affect the particular sites utilized.)
- •Females who are pregnant, who are trying to get pregnant or who have a urine test positive for pregnancy on the day of the study (For Induced Febrile Subjects only)
- •Subjects with known respiratory conditions such as:
- •uncontrolled / severe asthma,
- •pneumonia / bronchitis,
- •shortness of breath / respiratory distress,
- •respiratory or lung surgery,
- •emphysema, COPD, lung disease
- •Subjects with self-reported heart or cardiovascular conditions such as:
- •Resting high blood pressure: systolic >140 mmHg or diastolic >90 mmHg on 3 consecutive readings (For Induced Febrile Subjects only)
- •have had cardiovascular surgery
- •chest pain (angina)
- •heart rhythms other than a normal sinus rhythm or with respiratory sinus arrhythmia
- •previous heart attack
- •blocked artery
- •unexplained shortness of breath
- •congestive heart failure (CHF)
- •history of stroke
- •transient ischemic attack
- •carotid artery disease
- •myocardial ischemia
- •myocardial infarction
- •cardiomyopathy
- •Self-reported health conditions as identified in the Health Assessment Form
- •diabetes,
- •thyroid disease (controlled and uncontrolled)
- •kidney disease / chronic renal impairment,
- •history of seizures (except childhood febrile seizures),
- •epilepsy,
- •history of unexplained syncope,
- •recent history of frequent migraine headaches,
- •recent head injury within the last 2 months,
- •Cancer / chemotherapy
- •Subjects with medical inflammatory conditions/taking antiinflammation medications
- •Barbiturates
- •Antipsychotics
- •Recent immunizations (within 1 month)
- •Subjects who have taken antipyretics in the last 240 minutes (aspirin, acetaminophen, ibuprofen)
- •Other known health condition, should be considered upon disclosure in health assessment form
结局指标
主要结局
Biometric
时间窗: 1-2 months
Biometric data collected from in-ear sensor device and compared to validated reference device
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Validation of a non-invasive in-ear sensor for oxygen saturation, heart rate and body core temperature measurementValidation measurement accuracy of a non-invasive in-ear sensor for body temperature, heart rate and oxygen saturationDRKS00012848niversitätsklinikum Schleswig-Holstein Campus Lübeck10
招募中
不适用
In-ear sensor technology for prehospital assessment of hypothermia and vital functions - a two-branch, observational studyHYPOTHERMIETRAUMADRKS00025028Klinikum der LMU München74
已完成
不适用
Establishing a Non-invasive Method to Measure Your Heart's PerformanceHeart FailureNCT02240979Marie Csete MD, PhD72
已完成
不适用
Electrode-Based Sensor for Non-Invasive Fetal Heart Rate Monitoring With Improved ReliabilityLaboring Women With Ultrasound and FSE MonitoringNCT02024165OBMedical Company71
已完成
早期 1 期
Electrode-based Sensor for Non-invasive Fetal Heart Rate and EMG Monitoring With Improved ReliabilityPregnancyNCT01400880Convergent Engineering, Inc.103